Vitamin K and Cognition in Coronary Heart Disease (NutriCog) (NCT06855953)
Vitamin K Supplementation to Improve Cognition of Patients With Coronary Heart Disease: a Randomized Controlled Pilot Study
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this pilot study is to obtain a preliminary assessment of the effect of VK supplementation on cognitive performance and vascular function in adults with stable Coronary Heart Disease (CHD)
Who can join: Review the eligibility criteria below.
Location: Montreal Heart Institute — Montreal, Quebec
Age range: 60 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Montreal Heart Institute — Montreal, Quebec
📞 Contact the Study Coordinator
Phone: (514) 376-3330
Email: guylaine.ferland@umontreal.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Coronary Heart Disease
- Project 3: ACHIEVE- CHD — Cleveland, Ohio
- Thiamine Intervention and Coronary Artery Bypass Grafting — Los Angeles, California
Explore by condition: All Coronary Heart Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.